Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Blood Sample Collection

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT04074720Recruiting

Prospective Breast Cancer Biospecimen Collection

NCT00909818Not ApplicableUnknown

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

NCT02159274Completed

Shoulder Disability and Late Symptoms Following Oncoplastic Breast Surgery

Showing all 3 trials

Research Network

Common Treatments

  • Blood Sample Collection1
  • Rectal Swab1
  • Tissue Sample Collection1
  • Standard Fractionated Radiotherapy1
  • Hypofractionated Radiotherapy1

Active Sponsors

  • Danish Cancer Society2
  • Danish Breast Cancer Cooperative Group1
  • Thomas Jefferson University1
  • University of Aarhus1

Top Investigators

Related Conditions

  • Breast Cancer3
  • Invasive Breast Cancer1

Activity Timeline